EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -2.237
March 31, 2026 1.524
December 31, 2025 -3.485
September 30, 2025 -2.588
June 30, 2025 -1.986
March 31, 2025 -1.785
December 31, 2024 -1.668
September 30, 2024 -2.523
June 30, 2024 -1.776
March 31, 2024 0.0647
December 31, 2023 -3.602
September 30, 2023 -4.075
June 30, 2023 -5.567
March 31, 2023 -117.17
Date Value
December 31, 2022 82.34
September 30, 2022 -2172.72
June 30, 2022 -2557.79
March 31, 2022 -3229.62
December 31, 2021 -28.43
September 30, 2021 -26.27
June 30, 2021 -25.51
March 31, 2021 -38.13
December 31, 2020 -30.54
September 30, 2020 -24.72
June 30, 2020 -32.55
March 31, 2020 -31.61
December 31, 2019 -44.14
September 30, 2019 -42.60

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Johnson & Johnson 0.0858
Eli Lilly & Co. 7.939

EPS Diluted (Quarterly) Related Metrics